SEARCH

SEARCH BY CITATION

References

  • Akaishi H, Takeda K, Kaisho T, Shineha R, Satomi S, Takeda J and Akira S (1998) Defective IL-2-mediated IL-2 receptor α chain expression in Stat3-deficient T lymphocytes. Int Immunol, 10, 17471751.
  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell JE (1999) Stat3 as an oncogene. Cell, 98, 295303.
  • Catlett-Falcone R et al. (1999) Constitutive activation of STAT3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105115.
  • Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P and Shuai K (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science, 278, 18031805.
  • Darnell JE (1997) STATs and gene regulation. Science, 277, 16301635.
  • Endo TA et al. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature, 387, 921924.
  • Frank DA, Robertson MJ, Bonni A, Ritz J and Greenberg M (1995) Interleukin 2 signaling involves the phosphorylation of Stat proteins. Proc Natl Acad Sci USA, 92, 77797783.
  • Fuchs B, Wagner T, Rössel N, Antoine M, Beug H and Niessing J (1997) Structure and erythroid cell-restricted expression of a chicken cDNA encoding a novel zinc finger protein of the Cys + His class. Gene, 195, 277284.
  • Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA and Greene WC (1995) Signaling through the interleukin 2 receptor β chain activates an STAT-5-like DNA-binding activity. Proc Natl Acad Sci USA, 92, 71927196.
  • Garcia, R and Jove R (1998) Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. J Biomed Sci, 5, 7985.
  • Gerwien J, Nielsen M, Labuda T, Nissen MH, Svejgaard A, Geisler C, Röpke C and Odum N (1999) Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. J Immunol, 163, 17421745.
  • Gilks CB, Bear SE, Grimes HL and Tsichlis PN (1993) Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein. Mol Cell Biol, 13, 17591768.
  • Gilmour K, Pine R and Reich NC (1995) Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci USA, 92, 1077210776.
  • Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS and Tweardy DJ (1998) Requirement of STAT3 but not STAT1 activation for epidermal growth factor receptor mediated cell growth in vitro. J Clin Invest, 102, 13851392.
  • Grimes HL, Chan TO, Zweidler-McKay PA, Tong B and Tsichlis PN (1996) The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol, 16, 62636272.
  • Haas K, Staller P, Geisen C, Bartek J, Eilers M and Möröy T (1997) Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene, 15, 179192.
  • Heinrich PC, Behrmann I, Müller-Newen G, Schaper F and Graeve L (1998) Interleukin-6-type cytokine signalling throug the gp130/Jak/STAT pathway. Biochem J, 334, 297314.
  • Hill CC and Treisman R (1995) Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. EMBO J, 14, 50375047.
  • Hogan B, Beddington R, Costantini F and Lacy E (1994) Manipulating the Mouse Embryo. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Hollenberg SM, Sternglanz R, Cheng PF and Weintraub H (1995) Identification of a new family of tissue specific helix–loop–helix proteins with a two hybrid system. Mol Cell Biol, 15, 38133822.
  • Ihle JN (1996) STATs: signal transducers and activators of transcription. Cell, 84, 331334.
  • Kordula T, Ryde RE, Brigham EF, Horn F, Heinrich PC and Travis J (1998) Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate α1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 273, 41124118.
  • Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE and Stark GR (1996). Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol, 16, 369375.
  • Liu B, Liao J, Rao X, Kushner SA, Chung CD, Chang DD and Shuai K (1998) Inhibition of Stat 1-mediated gene activation by PIAS 1. Proc Natl Acad Sci USA, 95, 1062610631.
  • Moriggl R et al. (1999) Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity, 10, 249259.
  • Möröy T, Grzeschiczek A, Petzold S and Hartmann KU (1993) Expression of a pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc Natl Acad Sci USA, 90, 1073410738.
  • Naka T et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature, 387, 924929.
  • Ng J and Cantrell D (1997) STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem, 272, 2454224549.
  • Nielsen M, Sveijgaard A, Skov S and Odum N (1994) Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of STAT3 in human T-lymphocytes. Eur J Immunol, 24, 30823086.
  • Rödel B, Wagner T, Zörnig M, Niessing J and Möröy T (1998) The human homologue (GFI1B) of the chicken GFI gene maps to chromosome 9q34.13-A locus frequently altered in hematopoietic diseases. Genomics, 54, 580582.
  • Scheijen B, Jonkers J, Acton D and Berns A (1997) Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice. J Virol, 71, 916.
  • Schindler C and Darnell JE (1995) Transcriptional responses to polypeptide ligands: The JAK–STAT pathway. Annu Rev Biochem, 64, 621651.
  • Schmidt T, Zörnig M, Beneke R and Möröy T (1996) MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res, 24, 25282534.
  • Schmidt T, Karsunky H, Gau E, Zevnik B, Elsasser HP and Möröy T (1998) Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene, 17, 26612667.
  • Shuai K (1999) The STAT family of proteins in cytokine signaling. Prog Biophys Mol Biol, 71, 405422.
  • Starr R et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917921.
  • Takeda, K, Kaisho T, Yoshida N, Takeda J, Kishimoto T and Akira S (1998) Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol, 161, 46524660.
  • Tong B, Grimes HL, Yang T-Y, Bear SE, Qin Z, Du K, el-Deiry WS and Tsichlis PN (1998) The Gfi-1B proto-oncoprotein represses p21waf1 and inhibits myeloid cell differentiation. Mol Cell Biol, 18, 24622473.
  • Zhumabekov T, Corbella P, Toliani M and Kioussis D (1995). Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J Immunol Methods, 185, 133140.
  • Zörnig M, Busch G, Beneke R, Gulbins E, Lang F, Ma A, Korsmeyer S and Möröy T (1995) Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes. Oncogene, 11, 21652174.
  • Zörnig M, Schmidt T, Karsunky H, Grzeschiczek A and Möröy T (1996) Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2. Oncogene, 12, 17891801.
  • Zweidler-McKay PA, Grimes HL, Flubacher MM and Tsichlis PN (1996) Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol, 16, 40244034.